JP2020132638A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020132638A5 JP2020132638A5 JP2020022548A JP2020022548A JP2020132638A5 JP 2020132638 A5 JP2020132638 A5 JP 2020132638A5 JP 2020022548 A JP2020022548 A JP 2020022548A JP 2020022548 A JP2020022548 A JP 2020022548A JP 2020132638 A5 JP2020132638 A5 JP 2020132638A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- cancer
- anticancer
- group
- integer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019023972 | 2019-02-13 | ||
| JP2019023972 | 2019-02-13 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020132638A JP2020132638A (ja) | 2020-08-31 |
| JP2020132638A5 true JP2020132638A5 (https=) | 2022-12-28 |
| JP7560255B2 JP7560255B2 (ja) | 2024-10-02 |
Family
ID=72262311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020022548A Active JP7560255B2 (ja) | 2019-02-13 | 2020-02-13 | ヘミアスタリン誘導体を含む抗体薬物複合体を含有する医薬 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP7560255B2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115286820B (zh) * | 2022-10-10 | 2022-12-16 | 佛山科学技术学院 | 一种光交联胶原基水凝胶及其制备方法和应用 |
| EP4671233A1 (en) * | 2023-06-29 | 2025-12-31 | Pinotbio, Inc. | NEW HEMIASTERLINE DERIVATIVE AND ITS USE |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9508195D0 (en) * | 1995-04-20 | 1995-06-07 | Univ British Columbia | Novel biologically active compounds and compositions,their use and derivation |
| DK2211904T3 (en) * | 2007-10-19 | 2016-10-24 | Seattle Genetics Inc | Cd19-binding agents and uses thereof |
| RU2583270C2 (ru) * | 2009-04-01 | 2016-05-10 | Дженентек, Инк. | АНТИТЕЛА К FcRH5, ИХ ИММУНОКОНЪЮГАТЫ И СПОСОБЫ ИХ ПРИМЕНЕНИЯ |
| WO2014057436A2 (en) * | 2012-10-10 | 2014-04-17 | Adamed Sp. Z O.O. | Anticancer conjugate |
| HK1220626A1 (zh) * | 2013-03-15 | 2017-05-12 | The Centre For Drug Research And Development | 具细胞毒性和抗有丝分裂的化合物以及其使用方法 |
| GB201402009D0 (en) * | 2014-02-06 | 2014-03-26 | Oncomatryx Biopharma S L | Antibody-drug conjugates and immunotoxins |
| PT3250237T (pt) * | 2015-01-30 | 2021-06-30 | Sutro Biopharma Inc | Derivados de hemiasterlina para conjugação e terapêutica |
| WO2015151079A2 (en) * | 2015-06-20 | 2015-10-08 | Hangzhou Dac Biotech Co, Ltd | Auristatin analogues and their conjugates with cell-binding molecules |
-
2020
- 2020-02-13 JP JP2020022548A patent/JP7560255B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11466158B2 (en) | Phthalocyanine dye compounds, conjugates and methods of use thereof | |
| WO2016187226A1 (en) | Sirp polypeptide compositions and methods of use | |
| JP7623413B2 (ja) | ヘミアスタリン誘導体を含む抗体薬物複合体 | |
| JP7605809B2 (ja) | ヘミアスタリン誘導体及びこれらの抗体薬物複合体 | |
| JP7519347B2 (ja) | キノリン誘導体を含む薬物複合体 | |
| JP2024532726A5 (https=) | ||
| JP2020132638A5 (https=) | ||
| JPWO2020166592A5 (https=) | ||
| JP7570641B2 (ja) | 癌の処置又は予防において使用する為のキノリン誘導体 | |
| JPWO2019031614A5 (https=) | ||
| KR20220041880A (ko) | 항체-폴리머 접합체 | |
| JP7479302B2 (ja) | ヘミアスタリン誘導体とその抗体薬物複合体 | |
| JP2016539129A5 (https=) | ||
| US20250270228A1 (en) | Compounds, compositions and methods | |
| JP7560255B2 (ja) | ヘミアスタリン誘導体を含む抗体薬物複合体を含有する医薬 | |
| US20170267753A1 (en) | Combination therapy for co-administration of monoclonal antibodies | |
| WO2022216978A1 (en) | Phthalocyanine dye compounds, conjugates and methods of use thereof | |
| CA3122912C (en) | Quinoline derivatives for use in the treatment or prevention of cancer | |
| TW202517255A (zh) | 化合物、組合物及方法 | |
| OA22197A (en) | Compounds, Compositions And Methods. | |
| CA3258890A1 (en) | N-SUBSTITUTED AND CONJUGATED INDOLE DERIVATIVES FOR CANCER TREATMENT |